These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1072 related articles for article (PubMed ID: 12912945)
1. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945 [TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680 [TBL] [Abstract][Full Text] [Related]
3. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma. Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of RASSF1A in head and neck cancer. Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151 [TBL] [Abstract][Full Text] [Related]
5. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441 [TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417 [TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Dong SM; Kim HS; Rha SH; Sidransky D Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914 [TBL] [Abstract][Full Text] [Related]
10. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer. Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812 [TBL] [Abstract][Full Text] [Related]
12. Association between RASSF1A Promoter Hypermethylation and Oncogenic HPV Infection Status in Invasive Cervical Cancer: a Meta-analysis. Li JY; Huang T; Zhang C; Jiang DJ; Hong QX; Ji HH; Ye M; Duan SW Asian Pac J Cancer Prev; 2015; 16(14):5749-54. PubMed ID: 26320446 [TBL] [Abstract][Full Text] [Related]
13. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730 [TBL] [Abstract][Full Text] [Related]
16. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865 [TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383 [TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722 [TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
20. Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population. Tran TN; Liu Y; Takagi M; Yamaguchi A; Fujii H J Oral Pathol Med; 2005 Mar; 34(3):150-6. PubMed ID: 15689228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]